Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-08-24Clinical Trial Update: A Study of Usage of Paliperidone Palmitate in Patients With Schizophrenia in a Hospital Setting
A completed clinical trial evaluating the usage of paliperidone palmitate for schizophrenia in a hospital setting.
-
CLINICAL_TRIALS other · 2015-08-24Clinical Trial Update: Anticholinergic Burden in Schizophrenia [NA]
Clinical trial update indicates that the study on anticholinergic burden in schizophrenia has been terminated.
-
CLINICAL_TRIALS research · 2015-08-21Clinical Trial Update: Psychiatric Disorders and Electrophysiological Markers [NA]
Clinical trial investigating psychiatric disorders and electrophysiological markers in schizophrenia; current status is not disclosed.
-
CLINICAL_TRIALS trial_result · 2015-08-21Clinical Trial Update: MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0557-027) [Phase 2]
Completed Phase 2 clinical trial of MK0557 for cognitive impairment in schizophrenia, including paranoid schizophrenia, sponsored by Merck S…
-
FDA approval · 2015-08-21FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for quetiapine fumarate from Aurobindo Pharma Limited, providing a generic version of the antips…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-08-20FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Geodon (ziprasidone mesylate) submitted by Viatris Specialty LLC to update the approved product.
-
FDA approval · 2015-08-20FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Geodon (ziprasidone) from Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2015-08-17Clinical Trial Update: Interest of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Auditory Hallucinations [Phase 2]
This update notes the completion of a Phase 2 study evaluating repetitive transcranial magnetic stimulation (rTMS) for auditory hallucinatio…
-
FDA approval · 2015-08-14FDA Approved: ARIPIPRAZOLE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal's original ANDA for aripiprazole (ARIPIPRAZOLE), enabling the marketing of a generic version of this antipsychotic.
-
FDA approval · 2015-08-12FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Saptalis Pharmaceuticals, LLC.)
FDA approved a supplemental application for chlorpromazine hydrochloride from Saptalis Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2015-08-11Clinical Trial Update: Assessing the Impact of Self-directed Care, Within a Medicaid-funded Environment,on Participation and Community Living [NA]
Completed clinical trial update evaluating the impact of self-directed care in a Medicaid-funded environment on participation and community …
-
CLINICAL_TRIALS trial_result · 2015-08-10Clinical Trial Update: Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder in Individuals With Severe Mental Illness [Phase 2]
Phase 2 results from a cognitive behavioral therapy intervention for post-traumatic stress disorder in individuals with schizophrenia or oth…
-
CLINICAL_TRIALS withdrawal · 2015-08-04Clinical Trial Update: A Survey of Sexual Function in Schizophrenic Patients
This clinical trial update notes that a study assessing sexual function in schizophrenia patients was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-08-03Clinical Trial Update: Deep Brain Stimulation (DBS) for the Management of Treatment Refractory Negative Symptoms in Schizophrenia [Phase 1]
A Phase 1 clinical trial evaluating deep brain stimulation for treatment-refractory negative symptoms in schizophrenia has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-07-30Clinical Trial Update: An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients With Schizophrenia [Phase 2]
A Phase 2 open study evaluating sulforaphane-rich broccoli sprout extract in patients with schizophrenia has completed at Chiba University.
-
CLINICAL_TRIALS trial_result · 2015-07-30Clinical Trial Update: 20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms [Phase 2]
A Phase 2 trial evaluating AMG 747 for negative symptoms in schizophrenia was terminated.
-
FDA label_change · 2015-07-29FDA Approved: ABILIFY MAINTENA — Supplemental Application (Otsuka America Pharmaceutical, Inc.)
FDA approved a supplemental application for ABILIFY MAINTENA (aripiprazole long-acting injectable) from Otsuka America Pharmaceutical, Inc.,…
-
FDA approval · 2015-07-23FDA Approved: ZYPREXA INTRAMUSCULAR — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Zyprexa Intramuscular (olanzapine) from Eli Lilly, adding the intramuscular formulation to the p…
-
FDA approval · 2015-07-23FDA Approved: ZYPREXA RELPREVV — Supplemental Application (H2-Pharma LLC)
The FDA approved a supplemental application for ZYPREXA RELPREVV (olanzapine pamoate) submitted by H2-Pharma LLC, related to the long-acting…
-
EMA withdrawal · 2015-07-20EMA Application withdrawn: Aripiprazole Mylan (aripiprazole) — Generics (UK) Limited
The EMA report indicates withdrawal of the aripiprazole generic application from Generics (UK) Limited for schizophrenia and bipolar disorde…
-
CLINICAL_TRIALS trial_result · 2015-07-16Clinical Trial Update: Randomized, Controlled, Double Blind Trial of Eszopiclone for Insomnia Associated With Schizophrenia [NA]
A randomized, double-blind trial evaluated eszopiclone for insomnia in individuals with schizophrenia, with results posted in July 2015.
-
FDA approval · 2015-07-10FDA Approved: REXULTI — Original Application (Otsuka America Pharmaceutical, Inc.)
FDA approved Rexulti (brexpiprazole) from Otsuka America Pharmaceutical as the original approval for the treatment of schizophrenia in adult…
-
CLINICAL_TRIALS trial_result · 2015-07-10Clinical Trial Update: Assessing the Effects of Fanapt® on Social Cognition in Schizophrenia [Phase 4]
A Phase 4 trial evaluating the effects of Fanapt (iloperidone) on social cognition in schizophrenia and schizoaffective disorder; the study …
-
CLINICAL_TRIALS trial_result · 2015-07-01Clinical Trial Update: Investigation of the Drug Dimethoxbenzylidene Anabaseine in Treating Schizophrenia Patients [Phase 1]
Phase 1 study of Dimethoxbenzylidene Anabaseine in patients with schizophrenia and psychotic disorders has completed. The update notes compl…
-
CLINICAL_TRIALS trial_result · 2015-06-24Clinical Trial Update: Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue [Phase 3]
Phase 3 trial evaluating liraglutide, a GLP-1 analogue, for antipsychotic-associated obesity and metabolic syndrome in schizophrenia; the st…